Reapplix is a regenerative medicine company offering a new solution to an old challenge.
Our mission is to change the life of patients with non-healing wounds by providing them with a new role in the management of their own wound.
Our promise is to provide clinicians with the tools to harness the patients’ own power from the patients’ blood without additional additives. We offer a proven alternative to other available wound management solutions such as those derived from donated cultured cells, human cadavers, placentas or animal derived collagen.
REAPPLIX
Reapplix was founded in 2008 by leading inventors and scientists and now offers a new solution for the treatment of chronic wounds such as diabetic foot ulcers. Based in Denmark, with sales teams in the US, UK and Germany, the innovative 3C Patch® is backed by strong clinical evidence and is now available for the benefit of patients and healthcare practitioners.